Peter Kies - 20 May 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
/s/ Peter Kies
Issuer symbol
INO
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 16:57:42 UTC
Previous filing
16 May 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIES PETER CFO C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE ROAD, SAN DIEGO /s/ Peter Kies 21 May 2025 0001259780

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Award $0 +26,100 $0.000000 26,100 20 May 2025 Common Stock 26,100 Direct F1
transaction INO Common Stock Option Award $0 +31,950 $0.000000 31,950 20 May 2025 Common Stock 31,950 $2.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The vesting schedule for the 31,950 options is as follows: 15,975 shares will vest on May 20, 2027 and 15,975 shares will vest on May 20, 2028.